Stocks
VanEck Biotech ETFBBH
NASDAQHealthcareBiotechnology$186.60-0.83%
This ETF provides targeted exposure to the biotechnology sector by tracking the performance of the MVIS US Listed Biotech 25 Index. Investors use BBH to gain diversified access to leading U.S.-listed biotech firms without picking individual stocks. The fund is particularly relevant for those seeking growth potential in drug development and medical innovation.
Market Cap: $391.3M52W Range: $135.34 – $202.91
Congressional Interest in VanEck Biotech ETF (BBH)
2 members of Congress have disclosed 4 trades in VanEck Biotech ETF (BBH), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 2 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
2
Buys
2
Sells
2
Who in Congress Is Trading BBH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-04 | Thomas Suozzi | sell | $50K – $100K |
| 2022-01-28 | Donald Sternoff Beyer | sell | $1K – $15K |